SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001591986-24-000003
Filing Date
2024-02-14
Accepted
2024-02-14 16:37:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 pirs_13gv3.htm SC 13G/A 81809
  Complete submission text file 0001591986-24-000003.txt   83651
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88917 | Film No.: 24639395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE LETTERMAN DRIVE SUITE D4900, BUILDING D SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE SUITE D4900, BUILDING D SAN FRANCISCO CA 94129 415-635-0140
Aquilo Capital Management, LLC (Filed by) CIK: 0001591986 (see all company filings)

IRS No.: 272448001 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A